HIV / AIDS in the News

Advocates puzzled after HIV is left off of Georgia’s ‘medically frail’ list for Medicaid work rules - Georgia Recorder

 

Global HIV response at risk as funding cuts raise fears of epidemic resurgence - United Nations in India

 

Donor cuts, govt inaction push HIV patients towards death, uncertainty in Rivers, Akwa Ibom (I) - Premium Times Nigeria

 

New report reveals consequences of Trump administration's HIV/AIDS funding cuts - PBS

 

The Next Step on the Path to an HIV Cure - amfAR | The Foundation for AIDS Research

 

WHO champions self-care for HIV, TB, hepatitis, sexually transmitted infections and mental health - World Health Organization (WHO)

 

Funding for the Global HIV Response Plunged in 2025, With Devastating Consequences - POZ

 

Gilead uses humor in ‘Up to Date’ HIV prevention push - Fierce Pharma

 

Global HIV Response Falters as Reemergence Looms - POZ

 

KPAI urges equal healthcare, education access for children with HIV - ANTARA News

 

HIV Dovato Noninferior to Biktarvy at 48 Weeks - Infectious Disease Special Edition

 

Hope grows as HIV care enters a new era - The Daily Star

 

The Eye of the Storm [Excerpt] - POZ

 

Childhood HBV Vaccination May Reduce HBV Coinfection in People With HIV - Infectious Disease Advisor

 

Once-Weekly Oral HIV Regimen Matches Daily Therapy in Phase 3 Trials - Infectious Disease Special Edition

 

World Hepatitis Day 2026: Hepatitis: Let’s Break It Down - European AIDS Treatment Group

 

Activists Disrupt Global AIDS Conference to Protest Trump’s Attack on HIV Funding - POZ

 

[AIDS 2026] Johns Hopkins Bloomberg School of Public Health: Lancet report recommends paradigm shift in care for older adults with HIV - European AIDS Treatment Group

 

Beyond blocking HIV: How tenofovir shapes the immune system - Fred Hutchinson Cancer Center

 

[AIDS 2026] [Report] KFF/UNAIDS: Donor government funding for HIV drops by $2.1 billion in 2025 - European AIDS Treatment Group

 

Lancet Report Recommends Paradigm Shift in Care for Older Adults with HIV | Newswise - Newswise

 

[AIDS 2026] [Press release] ViiV Healthcare’s 2-drug regimen Dovato is as effective as 3-drug regimen Biktarvy in first-of-its-kind head-to-head study in treatment-naïve adults living with HIV - European AIDS Treatment Group

 

World risks HIV resurgence as funding falls 18 per cent, UNAIDS says - sightmagazine.com.au

 

World risks HIV resurgence as funding falls 18%, UNAIDS says - Reuters

 

In HelloNation, Healthcare Expert Kim McKenna Breaks Down HIV and Hepatitis Care in Rural Kentucky - PR Newswire

 

HIV/AIDS Research, Innovation Persist Despite PEPFAR Funding Cuts - The Washington Informer

 

Updating the tools needed to fight an evolving HIV - fredhutch.org

 

Merck (MRK) Is Up 5.4% After Expanding HIV PrEP Access And Launching Oral Cholesterol Drug - Yahoo Finance

 

Dovato Shows Noninferior Efficacy to Biktarvy in Head-to-Head HIV Trial - Contagion Live

 

KFF-UNAIDS report shows sharp drop in funding for the HIV response | AIDS 2026 - Managed Healthcare Executive